The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
Open accessAbstract
BackgroundIn Côte d’Ivoire, acute leukemias account for 12.5% of hematological malignancies. Acute leukemias are due to an anomaly of the stem cell characterized among other things by the expression of CD34+ CD38- surface markers. This CD34+ CD38- phenotype as well as other factors such as tumor syndrome, high leukocytosis and blasts are considered as important factors of poor prognosis. We therefore proposed to investigate the prognostic value of the expression of CD34+ CD38- markers in acute leukemias in Abidjan.MethodsWe selected 23 patients aged 33 years on whom we performed Complete Blood Count, bone marrow aspiration and immunophenotyping. To search for myeloperoxydase, smears of blood or bone marrow were stained with benzidine and revealed by the use of Hydrogen peroxide. Acute leukemias were then identified and distributed using the score proposed by the European Group for the Immunological characterization of Leukemias. The definitive diagnosis was made by combining morphological characters that serve as the basis for the French-American-British classification as well as cytochemical and immunophenotypic characters.ResultsAccording to the cytological and immunophenotypic classifications, the acute lymphoid leukemia 2 and B IV predominated. 52.2% (12/33) of patients were CD34+ CD38-. This phenotype was found in almost all cytological immunophenotypic types. The medullary invasion by blasts (reflection of the tumor mass) of the total sample of CD34+ , CD34+ CD38- patients and those not expressing CD34+ was respectively 79.4%, 81.25%, 83.3% and 74.8%.ConclusionThere was therefore no correlation between medullary blasts and the expression of CD34+ CD38-. To the factors we selected it would have been necessary to associate the study ofcytogenetic and molecular anomalies to better understand the role of CD34+ CD38- phenotype, concerning prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Goodell, M. A., Rosenzweig, M., Kim, H., Marks, D. F., DeMaria, M., Paradis, G., Grupp, S. A., Sieff, C. A., Mulligan, R. C., & Johnson, R. P. (1997) · Nature Medicine · doi:10.1038/nm1297-1337 · Cited by 1,089
Leith, C. P., Kopecky, K. J., Godwin, J., McConnell, T., Slovak, M. L., Chen, I.-M., Head, D. R., Appelbaum, F. R., & Willman, C. L. (1997) · Blood · doi:10.1182/blood.v89.9.3323 · Cited by 859
Cheson, B. D., Cassileth, P. A., Head, D. R., Schiffer, C. A., Bennett, J. M., Bloomfield, C. D., Brunning, R., Gale, R. P., Grever, M. R., & Keating, M. J. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.5.813 · Cited by 770
Leith, C. P., Kopecky, K. J., Chen, I. M., Eijdems, L., Slovak, M. L., McConnell, T. S., Head, D. R., Weick, J. K., Grever, M. R., Appelbaum, F. R., et al. (1999) · PubMed · doi:10.1182/blood.v94.3.1086.415k32_1086_1099 · Cited by 573
Expression of breast cancer resistance protein in blast cells from patients with acute leukemia
Ross, D. D., Karp, J. E., Chen, T. T., & Doyle, L. A. (2000) · Blood · doi:10.1182/blood.v96.1.365 · Cited by 250
Steinbach, D., Sell, W., Voigt, A., Hermann, J., Zintl, F., & Sauerbrey, A. (2002) · Leukemia · doi:10.1038/sj.leu.2402541 · Cited by 226
Wilson, C. S. (2006) · Blood · doi:10.1182/blood-2004-12-4633 · Cited by 190
Breast Cancer Resistance Protein and P-Glycoprotein in 149 Adult Acute Myeloid Leukemias
Benderra, Z., Faussat, A.-M., Sayada, L., Perrot, J.-Y., Chaoui, D., Marie, J.-P., & Legrand, O. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0795 · Cited by 188
Vaults: a ribonucleoprotein particle involved in drug resistance?
Mossink, M. H., van Zon, A., Scheper, R. J., Sonneveld, P., & Wiemer, E. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206947 · Cited by 187
Lowenberg, B., van Putten, W., Touw, I. P., Delwel, R., & Santini, V. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303043280904 · Cited by 180
van den Heuvel-Eibrink, M., Wiemer, E., Prins, A., Meijerink, J., Vossebeld, P., van der Holt, B., Pieters, R., & Sonneveld, P. (2002) · Leukemia · doi:10.1038/sj.leu.2402496 · Cited by 175
van der Kolk, D. M., Vellenga, E., Scheffer, G. L., Müller, M. M., Bates, S. E., Scheper, R. J., & de Vries, E. G. E. (2002) · Blood · doi:10.1182/blood.v99.10.3763 · Cited by 133
Damiani, D., Tiribelli, M., Calistri, E., Geromin, A., Chiarvesio, A., Michelutti, A., Cavallin, M., & Fanin, R. (2006) · PubMed · Cited by 125
Low levels of ABCG2 expression in adult AML blast samples
Abbott, B. L., Colapietro, A.-M., Barnes, Y., Marini, F. C., Andreeff, M., & Sorrentino, B. P. (2002) · Blood · doi:10.1182/blood-2002-01-0271 · Cited by 121
Raaijmakers, M. H. G. P., de Grouw, E. P. L. M., Heuver, L. H. H., van der Reijden, B. A., Jansen, J. H., Scheper, R. J., Scheffer, G. L., de Witte, T. J. M., & Raymakers, R. A. P. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0212 · Cited by 106
Expression of the Lung Resistance Protein Predicts Poor Outcome in De Novo Acute Myeloid Leukemia
Filipits, M., Pohl, G., Stranzl, T., Suchomel, R. W., Scheper, R. J., Jäger, U., Geissler, K. H., Lechner, K., & Pirker, R. (1998) · Blood · doi:10.1182/blood.v91.5.1508 · Cited by 103
BCRP mRNA expression v. clinical outcome in 40 adult AML patients
Uggla, B., Ståhl, E., Wågsäter, D., Paul, C., Karlsson, M. G., Sirsjö, A., & Tidefelt, U. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.06.004 · Cited by 103
van den Heuvel‐Eibrink, M. M., van der Holt, B., Boekhorst, P. A. W. T., Pieters, R., Schoester, M., Löwenberg, B., & Sonneveld, P. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.3343148.x · Cited by 99
ABCG2 (BCRP) expression in normal and malignant hematopoietic cells
Abbott, B. L. (2003) · Hematological Oncology · doi:10.1002/hon.714 · Cited by 87
George, A. A., Franklin, J. L., Kerkof, K., Shah, A. J., Price, M. A., Tsark, E. C., Bockstoce, D. C., Yao, D., Hart, N., Carcich, S., et al. (2001) · Blood · doi:10.1182/blood.v97.12.3925 · Cited by 83
van der Kolk, D. M., de Vries, E., Noordhoek, L., van den Berg, E., van der Pol, M., Müller, M. M., & Vellenga, E. (2001) · Leukemia · doi:10.1038/sj.leu.2402236 · Cited by 79
van der Pol, M. A., Broxterman, H. J., Pater, J. M., Feller, N., van der Maas, M., Weijers, G. W. D., Scheffer, G. L., Jd, A., Scheper, R. J., van Loevezijn, A., et al. (2003) · PubMed · Cited by 71
Zhou, S., Zong, Y., Lu, T., & Sorrentino, B. P. (2003) · BioTechniques · doi:10.2144/03356ss04 · Cited by 64
Suvannasankha, A., Minderman, H., O’Loughlin, K. L., Nakanishi, T., Ford, L. A., Greco, W. R., Wetzler, M., Ross, D. D., & Baer, M. R. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05211.x · Cited by 63
Sonoda, Y. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.12.004 · Cited by 62
The Spectrum of Cancers in West Africa: Associations with Human Immunodeficiency Virus
Tanon, A., Jaquet, A., Ekouévi, D. K., Akakpo, J., Adoubi, I., Diomandé, I., Houngbé, F., Zannou, M. D., Sasco, A. J., Eholié, S. P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048108 · Cited by 58
Witte, K.-E., Ahlers, J., Schäfer, I., Andre, M. C., Kerst, G., Scheel‐Walter, H., Schwarze, C. P., Pfeiffer, M. M., Lang, P., Handgretinger, R., et al. (2011) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2010.528171 · Cited by 56
Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome
Ross, D. D. (2004) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.014 · Cited by 50
Israeli, D., Ziaei, S., Gonin, P., & García, L. (2004) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2004.07.018 · Cited by 30
Ebinger, M., Witte, K.-E., Ahlers, J., Schäfer, I., Andre, M. C., Kerst, G., Scheel‐Walter, H., Lang, P., & Handgretinger, R. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.03.023 · Cited by 28
Enjeux et perspectives de la prévention des cancers dans les pays en développement
Ly, A. (2011) · Journal africain du cancer / African Journal of Cancer · doi:10.1007/s12558-011-0178-5 · Cited by 6
Cited by
The changing global patterns of female breast cancer incidence and mortality
Bray, F., McCarron, P., & Parkin, D. M. (2004) · Breast Cancer Research · doi:10.1186/bcr932 · Cited by 1,007
Farge, T., Saland, E., de Toni, F., Aroua, N., Hosseini, M., Perry, R., Bosc, C., Sugita, M., Stuani, L., Fraisse, M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0441 · Cited by 912
on behalf of the EuroFlow Consortium (EU-FP6, L.-C.-2.-0., van Dongen, J. J. M., Lhermitte, L., Böttcher, S., Almeida, J., van der Velden, V. H. J., Flores-Montero, J., Rawstron, A., Asnafi, V, Lécrevisse, Q., et al. (2012) · Leukemia · doi:10.1038/leu.2012.120 · Cited by 934
Taitt, H. E. (2018) · American Journal of Men's Health · doi:10.1177/1557988318798279 · Cited by 463
Silva, A., Yunes, J. A., Cardoso, B. A., Martins, L. R., Jotta, P. Y., Abecasis, M., Nowill, A. E., Leslie, N. R., Cardoso, A. A., & Barata, J. T. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34616 · Cited by 443
Metadata
- Authors
- Sawadogo, D., Tolo, A., Kassi, H., Sangare, M., & Inwoley, A.
- Venue
- Mediterranean Journal of Hematology and Infectious Diseases
- Publisher
- Hematology Section, Dept. of Radiological Science and Hematology, Catholic University, Rome, Italy
- Published
- 2013-04-10
- Volume
- 5
- Issue
- 1
- Pages
- e2013023
- ISSN
- 2035-3006 (ISSN-L)
- OpenAlex
- W2158240777
- Cited by
- 381
- References
- 34
- FWCI
- 16.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.